Mandatum Life Insurance Company’s Celgene Corp CELG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q4
Sell
-37,939
Closed -$3.77M 143
2019
Q3
$3.77M Buy
37,939
+14,645
+63% +$1.39M 0.75% 38
2019
Q2
$2.15M Hold
23,294
0.45% 55
2019
Q1
$2.2M Hold
23,294
0.48% 55
2018
Q4
$1.49M Hold
23,294
0.36% 63
2018
Q3
$2.08M Hold
23,294
0.4% 57
2018
Q2
$1.85M Hold
23,294
0.35% 60
2018
Q1
$2.08M Hold
23,294
0.39% 56
2017
Q4
$2.43M Hold
23,294
0.38% 56
2017
Q3
$3.4M Hold
23,294
0.46% 35
2017
Q2
$3.02M Hold
23,294
0.41% 40
2017
Q1
$2.9M Hold
23,294
0.38% 52
2016
Q4
$2.7M Hold
23,294
0.37% 54
2016
Q3
$2.44M Hold
23,294
0.32% 55
2016
Q2
$2.3M Hold
23,294
0.31% 55
2016
Q1
$2.33M Hold
23,294
0.31% 58
2015
Q4
$2.79M Buy
+23,294
New +$2.69M 0.38% 37

Other funds holding CELG

Mandatum Life Insurance Company's CELG Position: Q4 2019 in Review

Mandatum Life Insurance Company sold out of Celgene Corp (CELG) in Q4 2019, closing a stake of 37,939 shares — an estimated $3.77M sold.

Mandatum Life Insurance Company first reported a position in CELG in Q4 2015 and held it in 16 quarters. The position peaked at $3.77M in Q3 2019. 4 funds tracked by Wall St. Rank hold CELG as of Q4 2019.

  • Mandatum Life Insurance Company reported no remaining Celgene Corp position as of Q4 2019 after selling out during the quarter.
  • Mandatum Life Insurance Company sold 37,939 Celgene Corp shares in Q4 2019, an estimated $3.77M.
  • Mandatum Life Insurance Company first reported a position in Celgene Corp in Q4 2015 and held it in 16 quarters.
  • Mandatum Life Insurance Company's Celgene Corp position peaked at $3.77M in Q3 2019.
  • 4 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2019.

Based on Mandatum Life Insurance Company's 13F filing for Q4 2019, filed 11 Feb 2020.